These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 720629)

  • 1. Increased formation of nucleotide derivatives of 5-fluorouridine in hepatoma cells treated with inhibitors of pyrimidine synthesis and D-galactosamine.
    Holstege A; Herrmann B; Keppler DO
    FEBS Lett; 1978 Nov; 95(2):361-5. PubMed ID: 720629
    [No Abstract]   [Full Text] [Related]  

  • 2. Uridine triphosphate deficiency, growth inhibition, and death in ascites hepatoma cells induced by a combination of pyrimidine biosynthesis inhibition with uridylate trapping.
    Keppler DO
    Cancer Res; 1977 Mar; 37(3):911-7. PubMed ID: 189918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tyrosine aminotransferase induction by UTP deficiency and its reversal by 5-fluorouridine in cultured hepatoma cells.
    Giesen EM; Beck G; Holstege A; Keppler DO
    Biochim Biophys Acta; 1981 Aug; 655(1):34-40. PubMed ID: 6167286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with D-galactosamine and 6-azauridine or N-(phosphonacetyl)-L-aspartate.
    Anukarahanonta T; Holstege A; Keppler DO
    Eur J Cancer (1965); 1980 Sep; 16(9):1171-80. PubMed ID: 6164559
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of antimetabolite action by uridylate trapping.
    Keppler D; Holstege A; Weckbecker G; Fauler J; Gasser T
    Adv Enzyme Regul; 1985; 24():417-27. PubMed ID: 3835824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
    Holstege A; Keppler D
    J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme pattern-directed chemotherapy. Effects of antipyrimidine combinations on the ribonucleotide content of hepatomas.
    Lui MS; Jackson RC; Weber G
    Biochem Pharmacol; 1979 Apr; 28(7):1189-95. PubMed ID: 444276
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of D-galactosamine on nucleotides in the rat heart. Effects of cytidine and uridine administration].
    Olivares J; Rossi A
    Arch Int Physiol Biochim; 1987 Mar; 95(1):1-11. PubMed ID: 2441669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
    Leube K; Keppler DO
    Biochem Pharmacol; 1983 Jun; 32(12):1865-9. PubMed ID: 6882463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice.
    Karle JM; Anderson LW; Dietrick DD; Cysyk RL
    Cancer Res; 1981 Dec; 41(12 Pt 1):4952-5. PubMed ID: 6171344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 6-azauridine on nucleotides, orotic acid, and orotidine in L5178Y mouse lymphoma cells in vitro.
    Janeway CM; Cha S
    Cancer Res; 1977 Dec; 37(12):4382-8. PubMed ID: 922730
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injury.
    Holstege A; Anukarahanonta T; Yamamoto M; Koch HK; Kattermann R; Lesch R; Keppler D
    Exp Mol Pathol; 1981 Apr; 34(2):170-82. PubMed ID: 6162676
    [No Abstract]   [Full Text] [Related]  

  • 14. Nucleotide contents of ascites hepatoma cells and their changes induced by D-galactosamine.
    Keppler DO; Smith DF
    Cancer Res; 1974 Apr; 34(4):705-11. PubMed ID: 4360835
    [No Abstract]   [Full Text] [Related]  

  • 15. Concurrent development of resistance to 6-azauridine and adenosine in a mouse cell line.
    Hashmi S; May SR; Krooth RS; Miller OJ
    J Cell Physiol; 1975 Oct; 86(2 Pt 1):191-200. PubMed ID: 1194360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary and metabolic manipulations of the carcinogenic process: role of nucleotide pool imbalances in carcinogenesis.
    Rao PM; Laconi E; Vasudevan S; Denda A; Rajagopal S; Rajalakshmi S; Sarma DS
    Toxicol Pathol; 1987; 15(2):190-3. PubMed ID: 2887029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine.
    Jackson RC; Williams JC; Weber G
    Cancer Treat Rep; 1976 Jul; 60(7):835-43. PubMed ID: 188552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of D-glucosamine and D-galactosamine on the uridine nucleotide concentration in mouse myeloid tumor (Graffi) and myeloma MOPC-21.
    Chelibonova-Lorer H
    Neoplasma; 1975; 22(1):23-7. PubMed ID: 1153035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of blood plasma cytidine due to increased hepatocellular salvage in D-galactosamine-treated rats.
    Holstege A; Manglitz D; Gerok W
    Eur J Biochem; 1984 Jun; 141(2):339-44. PubMed ID: 6734601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation and properties or uridine kinase from Zajdela hepatoma cells].
    Dubinina IG; Shkurko VG; Vornovitskaia GI
    Biokhimiia; 1981 Oct; 46(10):1905-16. PubMed ID: 6272884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.